We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · September 02, 2020

Tau PET Tracer RO948 F18 Differentiates Alzheimer Disease From Other Disorders

JAMA Neurology


Additional Info

JAMA Neurology
Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders
JAMA Neurol 2020 Aug 01;77(8)955-965, A Leuzy, R Smith, R Ossenkoppele, A Santillo, E Borroni, G Klein, T Ohlsson, J Jögi, S Palmqvist, N Mattsson-Carlgren, O Strandberg, E Stomrud, O Hansson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading